Jianru Shi Selected Research

Jianru Shi Research Topics

Disease

9	Myocardial Infarction 01/2023 - 10/2013
5	Ventricular Remodeling 07/2019 - 12/2014
4	Cardiomyopathies (Cardiomyopathy) 11/2014 - 09/2010
3	Inflammation (Inflammations) 11/2023 - 01/2020
3	Hemorrhagic Shock 12/2020 - 01/2019
3	Infarction (Infarctions) 11/2020 - 12/2014
3	Shock 01/2020 - 01/2019
3	Fibrosis (Cirrhosis) 11/2015 - 04/2009
2	No-Reflow Phenomenon 01/2023 - 11/2017
2	Pneumonia (Pneumonitis) 12/2022 - 01/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2020 - 07/2019
2	Reperfusion Injury 09/2017 - 01/2016
2	Amyloidosis 09/2013 - 03/2010
2	Heart Failure 01/2013 - 03/2010
1	Body Weight (Weight, Body) 01/2023
1	Hypothermia 12/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Lung Injury 01/2020
1	Brain Infarction 01/2020
1	Ischemia 09/2017
1	ST Elevation Myocardial Infarction 01/2016
1	Cicatrix (Scar) 12/2014
1	Immunoglobulin Light-chain Amyloidosis 11/2014
1	Cardiotoxicity 11/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2013
1	Disease Progression 10/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Hyperhomocysteinemia 01/2013
1	Left Ventricular Dysfunction 09/2010
1	Hypoxia (Hypoxemia) 09/2010
1	Familial Primary Pulmonary Hypertension 08/2008
1	Atherosclerosis 07/2004

Drug/Important Bio-Agent (IBA)

5	Nicotine FDA Link 11/2023 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 11/2014 - 03/2010
3	Amyloid (Amyloid Fibrils)IBA 11/2014 - 03/2010
2	SmokeIBA 01/2023 - 12/2022
2	CollagenIBA 01/2023 - 01/2013
2	Vitamin E FDA LinkGeneric 12/2022 - 01/2020
2	Oxygen (Dioxygen)IBA 11/2020 - 09/2010
2	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 11/2015 - 12/2014
2	Peptides (Polypeptides)IBA 11/2015 - 12/2014
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2014 - 09/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 04/2009
1	Flavoring AgentsIBA 11/2023
1	GasesIBA 12/2020
1	Anesthetics (Anesthetic Agents)IBA 01/2020
1	nichromeIBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	ElementsIBA 01/2020
1	FibrinIBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	E-Cigarette VaporIBA 01/2020
1	Isoflurane FDA LinkGeneric 01/2020
1	Ketamine FDA LinkGeneric 01/2020
1	Xylazine (Xylazin)IBA 01/2020
1	NitrogenIBA 01/2019
1	Urea (Carbamide)FDA LinkGeneric 01/2019
1	Cardiolipins (Cardiolipin)IBA 11/2015
1	Adenosine Triphosphate (ATP)IBA 11/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014
1	Therapeutic UsesIBA 12/2014
1	Sirolimus (Rapamycin)FDA Link 11/2014
1	Messenger RNA (mRNA)IBA 10/2013
1	ApolipoproteinsIBA 10/2013
1	Apolipoproteins E (ApoE)IBA 10/2013
1	high density lipoprotein receptorsIBA 10/2013
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2013
1	Apolipoproteins D (Apo D)IBA 10/2013
1	CalciumIBA 09/2013
1	HomocysteineIBA 01/2013
1	Renin InhibitorsIBA 01/2013
1	Cytokine TWEAKIBA 01/2013
1	aliskiren FDA Link 01/2013
1	ReninIBA 01/2013
1	CytokinesIBA 01/2013
1	EnzymesIBA 09/2010
1	factor AIBA 09/2010
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 09/2010
1	Transcription Factors (Transcription Factor)IBA 09/2010
1	TWEAK ReceptorIBA 04/2009
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 08/2008
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 07/2004

Therapy/Procedure

6	Therapeutics 01/2020 - 03/2010
3	Induced Hypothermia 12/2020 - 09/2017
2	Resuscitation 12/2020 - 01/2019
1	Intravenous Administration 11/2013
1	Intravenous Injections 01/2013